What is the official website of Chugai Pharmaceutical Co., Ltd. ?

The official website of Chugai Pharmaceutical Co., Ltd. is http://www.chugai-pharm.co.jp.

What is Chugai Pharmaceutical Co., Ltd.'s cybersecurity risk score?

Chugai Pharmaceutical Co., Ltd. has an AI-generated cybersecurity risk score of 758 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Chugai Pharmaceutical Co., Ltd. experienced?

According to Rankiteo, Chugai Pharmaceutical Co., Ltd. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Chugai Pharmaceutical Co., Ltd. been affected by any supply chain cyber incidents ?

According to Rankiteo, Chugai Pharmaceutical Co., Ltd. has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Chugai Pharmaceutical Co., Ltd. have SOC 2 Type 1 certification ?

According to Rankiteo, Chugai Pharmaceutical Co., Ltd. is not certified under SOC 2 Type 1.

Does Chugai Pharmaceutical Co., Ltd. have SOC 2 Type 2 certification ?

According to Rankiteo, Chugai Pharmaceutical Co., Ltd. does not hold a SOC 2 Type 2 certification.

Does Chugai Pharmaceutical Co., Ltd. comply with GDPR ?

According to Rankiteo, Chugai Pharmaceutical Co., Ltd. is not listed as GDPR compliant.

Does Chugai Pharmaceutical Co., Ltd. have PCI DSS certification ?

According to Rankiteo, Chugai Pharmaceutical Co., Ltd. does not currently maintain PCI DSS compliance.

Does Chugai Pharmaceutical Co., Ltd. comply with HIPAA ?

According to Rankiteo, Chugai Pharmaceutical Co., Ltd. is not compliant with HIPAA regulations.

Does Chugai Pharmaceutical Co., Ltd. have ISO 27001 certification ?

According to Rankiteo,Chugai Pharmaceutical Co., Ltd. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Chugai Pharmaceutical Co., Ltd. operate in ?

Chugai Pharmaceutical Co., Ltd. operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Chugai Pharmaceutical Co., Ltd. have ?

Chugai Pharmaceutical Co., Ltd. employs approximately 1,116 people worldwide.

Does Chugai Pharmaceutical Co., Ltd. own any subsidiaries ?

Chugai Pharmaceutical Co., Ltd. presently has no subsidiaries across any sectors.

How many LinkedIn followers does Chugai Pharmaceutical Co., Ltd. have ?

Chugai Pharmaceutical Co., Ltd.'s official LinkedIn profile has approximately 13,644 followers.

What is the NAICS classification code for Chugai Pharmaceutical Co., Ltd. ?

Chugai Pharmaceutical Co., Ltd. is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Chugai Pharmaceutical Co., Ltd. have a Crunchbase profile ?

No, Chugai Pharmaceutical Co., Ltd. does not have a profile on Crunchbase.

Does Chugai Pharmaceutical Co., Ltd. have a LinkedIn profile ?

Yes, Chugai Pharmaceutical Co., Ltd. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/chugai.

How many cybersecurity incidents has Chugai Pharmaceutical Co., Ltd. experienced ?

As of July 30, 2026, Rankiteo reports that Chugai Pharmaceutical Co., Ltd. has not experienced any cybersecurity incidents.

How many peer or competitor companies does Chugai Pharmaceutical Co., Ltd. have ?

Chugai Pharmaceutical Co., Ltd. has an estimated 5,718 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

CPCL

Boost Score +25 with badge (5 left)

758

/1000

Fair

783

/1000

Fair

Chugai Pharmaceutical Co., Ltd. Vendor Cyber Rating & Cyber Score

chugai-pharm.co.jp

Add Your Compliance Badge

Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/ Read our Social Media Policy:

CPCL A.I CyberSecurity Scoring

Scoring History

CPCL

Chugai Pharmaceutical Co., Ltd. CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

CPCL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for CPCL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Chugai Pharmaceutical Co., Ltd. in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Chugai Pharmaceutical Co., Ltd. in 2026.

Incident Types CPCL vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Chugai Pharmaceutical Co., Ltd. in 2026.

Incident History - CPCL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Chugai Pharmaceutical Co., Ltd. Subsidiaries

CPCL

Pharmaceutical Manufacturing

Website: http://www.chugai-pharm.co.jp

Company Size: 5,001-10,000 employees

RocheBiotechnology Research

Roche DeutschlandBiotechnologieforschung

GenentechBiotechnology Research

Genentech MedicalBiotechnology Research

Roche Middle EastBiotechnology Research

Roche Diabetes CareMedical Equipment Manufacturing

Carmot Therapeutics, Inc.Biotechnology Research

Roche MéxicoPharmaceutical Manufacturing

Ventana Medical SystemsBiotechnology Research

Roche Diagnostics BelgiumBiotechnology Research

GenMark DiagnosticsMedical Equipment Manufacturing

Roche DanmarkForskning inden for bioteknologi

Roche AustraliaBiotechnology Research

Roche Malaysia Penyelidikan Bioteknologi

Roche Sequencing USABiotechnology Research

LabLeadersHospitals and Health Care

Roche VietnamBiotechnology Research

Roche Diagnostics DanmarkMedical Equipment Manufacturing

Roche Tunisiaتصنيع المستحضرات الصيدلانية

Roche Diagnostics Asia PacificBiotechnology Research

Roche Diagnostics SwedenHospitals and Health Care

Roche in Belgium & LuxembourgBiotechnology Research

Roche Diagnostics AustraliaBiotechnology Research

Roche HungaryBiotechnology Research

Roche Diagnostics NederlandHospitals and Health Care

Roche Hong Kong 羅氏香港Biotechnology Research

Roche IndonesiaBioteknologi

Roche IsraelPharmaceutical Manufacturing

Roche SwedenTillverkning av läkemedel

Roche ChileFabricación de productos farmacéuticos

Roche FranceRecherche en biotechnologie

Roche Diabetes Care FranceFabrication d’équipements médicaux

Roche Diagnostics FranceFabrication d’équipements médicaux

Roche ArgentinaFabricación de productos farmacéuticos

Roche in AustriaArzneimittelherstellung

Roche Česká republikaBiotechnologie

Healthcare TransformersBiotechnology Research

Roche i NorgeSykehus og helsetjenester

Roche PerúFabricación de productos farmacéuticos

Roche Diagnostics PakistanBiotechnology Research

Roche Costa RicaInvestigación biotecnológica

Roche AfricaBiotechnology Research

Roche Diagnostics USABiotechnology Research

Roche LATAMPesquisa biotecnológica

Roche PolskaProdukcja wyrobów farmaceutycznych

Roche EcuadorFabricación de productos farmacéuticos

Roche UruguayFabricación de productos farmacéuticos

Roche BangladeshPharmaceutical Manufacturing

Roche CustomBiotech - North AmericaBiotechnology Research

Fondation RocheOrganisations à but non lucratif

Roche CanadaBiotechnology

Loading…

Chugai Pharmaceutical Co., Ltd. Similar Companies

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Loading…

NEWS

Chugai Pharmaceutical Co., Ltd. CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-67595

SUMMARY

VaahCMS versions 2.0.0 through 2.3.4 contain a malicious obfuscated JavaScript payload embedded in the Blade template responsible for rendering security OTP emails, allowing remote attackers to execute unauthorized code in any browser that renders the affected email template with JavaScript enabled. The payload establishes a WebSocket connection to a hardcoded command-and-control endpoint, installs a password-field keylogger using MutationObserver to capture dynamically added inputs, scrapes WhatsApp Web DOM content, and accepts remote commands to redirect or overwrite the rendered page.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.2

REFERENCES

CVE-2026-15157

SUMMARY

undici does not validate the type property of a duck-typed blob-like request body before using it as the Content-Type header on the HTTP/1.1 dispatcher. In undici before 6.28.0, from 7.0.0 up to before 7.29.0, and from 8.0.0 up to before 8.9.0, an application that passes a hand-rolled blob-like body (via request, stream, pipeline, or dispatch) whose type is derived from untrusted input allows an attacker to inject CRLF sequences and append arbitrary HTTP headers, potentially smuggling a second request past the upstream. Native Blob objects are safe because their constructor strips CRLF from the type, and fetch is unaffected because it validates headers, but ecosystem libraries that build duck-typed blob shapes from user input can reach the vulnerable path. This is the same defect class as CVE-2022-35948 and CVE-2026-1527, on a header sink that the earlier fixes did not cover. The issue is fixed in undici 6.28.0, 7.29.0, and 8.9.0.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: 4.2)

cvss3

Base Score: 4.2

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

1.6

REFERENCES

CVE-2026-14643

SUMMARY

undici's cache interceptor mishandles optional whitespace placed around the equals sign of a qualified no-cache or private Cache-Control directive. In undici from 7.0.0 up to before 7.29.0 and from 8.0.0 up to before 8.9.0, the parser either drops the directive or stores a field name with literal quote characters, so the cache decision fails to recognize the qualification and the response is stored. In shared-cache mode, this lets a response containing one user's authenticated data be served from cache to a later caller, including an unauthenticated one, when both requests resolve to the same cache key. It affects applications that enable the cache interceptor in shared mode, forward Authorization headers upstream, and receive cacheable responses with qualified directives padded with whitespace around the equals sign. This is the whitespace-around-equals variant that the fix for CVE-2026-9678 did not normalize, and it is fixed in undici 7.29.0 and 8.9.0.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2025-69949

SUMMARY

kishan0725 Hospital Management System 4.0 is vulnerable to SQL Injection in check_availability.php via the parameters emailid and email.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2025-69945

SUMMARY

kishan0725 Hospital Management System 4.0 is vulnerable to SQL Injection in /doctor/edit-patient.php?editid=1.

Published

Date2026-07-29

Updated

Date2026-07-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://github.com/um-dsp/TaintRadar/blob/main/sql_injection_cves/hospitalmanagementsystemproject/20250811-hospital-management-system-edit-patient.php-editid-sqli/20250811-hospital-management-system-edit-patient.php-editid-sqli.md

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…